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Abstract The mitochondrial permeability transition pore, a 
cyclosporin A-sensitive channel, is controlled by the transmem-
brane electric potential difference across the inner membrane. 
Here, we show that treatment of rat liver mitochondria with the 
arginine reagent phenylglyoxal inhibits the permeability transi-
tion pore triggered by depolarization with uncoupler after Ca 2 + 
accumulation. Phenylglyoxal does not change the extent of 
mitochondrial C a 2 + uptake or the extent of membrane 
depolarization, indicating that covalent modification of arginine 
(and possibly lysine) residues directly affects the open probability 
of the pore. We propose that arginine residues play a role in the 
physiological control of the permeability transition pore by the 
mitochondrial transmembrane potential. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The inner membrane of mitochondria contains a complex 
channel, the permeability transition (PT) pore. When fully 
open, this channel permits passive diffusion of solutes with a 
molecular weight up to 1500 Da, corresponding to a bore 
diameter of 2-3 n m [1]. The immunosuppressive peptide cy-
closporin A (CsA) inhibits the pore at nanomolar concentra-
tions by binding to matrix cyclophilin, which may lead to its 
dissociation from the inner mitochondrial membrane and pos-
sibly from its putative binding sites on the pore [2,3]. The PT 
pore is controlled by several ligands as well as by the electric 
potential difference (A\|/) across the inner mitochondrial mem-
brane; at high values of A\|/ the closed conformation prevails 
whereas a decrease in the A\|/ can trigger pore opening [4,5]. 
The pore is activated by Ca 2 + from the mitochondrial matrix 
and by an increase in the reduction potential of intramito-
chondrial pyridine nucleotides and glutathione [6,7]. 
Chemical modification of specific amino-acid residues has 
proven of great value in the characterization of the pore in 
intact mitochondria. Previous work using histidine- and cys-
teine-specific reagents has allowed the identification of three 
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separate sites that participate in the control of the PT : matrix 
histidine(s) conferring p H sensitivity [8]; the S-site, a dithiol 
which undergoes dithiol-disulfide interconversions [6,9] 
through matrix glutathione [7]; and the P-site, a NEM-reac-
tive site which is in redox equilibrium with pyridine nucleo-
tides [6,7]. 
In this study, we have tested the potential role of arginine 
residues in the regulation of the PT pore by characterizing the 
effect of the arginine-specific reagent, phenylglyoxal (PGO) 
[10]. Our results show that treatment of intact mitochondria 
with P G O inhibits the PT pore triggered by depolarization 
with uncoupler after Ca 2 + accumulation. P G O does not mod-
ify the extent of mitochondrial Ca 2 + uptake or the extent of 
uncoupler-induced membrane depolarization, indicating that 
covalent modification of arginine residues directly affects the 
open probability of the pore. These findings suggest that ar-
ginine residues located on the channel itself or on some of its 
regulatory component(s) play a crucial role in the regulation 
of the PT pore by the Av|/. 
2. Materials and methods 
Rat liver mitochondria were isolated from male Wistar rats (200-
300 g) as described previously [11]. To induce chemical modification 
of arginine residues, mitochondria were pre-incubated with PGO at 
20°C for 15 min in a buffer containing 250 mM sucrose, 20 uM 
ethylene-bis(oxoethylenenitrilo) tetraacetic acid (EGTA)-Tris, 10 
mM 4-(2-hydroxyethyl)-l-piperazine-ethanesulphonic acid (HEPES)-
KOH pH 8.0. The reaction was terminated by adjusting the pH to 
6.8 with HEPES and by cooling to 4°C whereupon mitochondria were 
sedimented by centrifugation at 8000 X g for 10 min. The pellet was re-
suspended at ~ 1 mg protein Xml - 1 in a medium containing 250 mM 
sucrose, 0.1 mM EGTA-Tris, 0.1 mM bovine serum albumin, 10 mM 
Tris-HCl pH 7.4 and the suspension was incubated at 4°C for 15 min. 
The centrifugation and incubation steps were repeated once and mi-
tochondria were finally re-suspended at =50 mg protein Xml - 1 in the 
same medium. Control mitochondria were treated exactly as above, 
except that PGO addition was omitted. Measurements were carried 
out in a medium containing 250 mM sucrose, 10 mM HEPES-Tris pH 
7.4, 3 mM succinate-Tris, 1 mM Pi-Tris, 2 uM rotenone. Mitochon-
drial swelling was measured at 570 nm with an Aminco DW2a dual-
wavelength spectrophotometer operated in the split-beam mode. Ca2+ 
transport was measured with the dye arsenazo III at the wavelength 
couple 653-684 nm [12] and A\|/ was measured with safranine at the 
wavelength couple 510-530 nm [13] with the Aminco DW2a operated 
in the dual-wavelength mode. Oxygen consumption was measured 
polarographically with a Clark electrode. Pi transport was measured 
in a medium containing 75 mM Pi-KOH pH 7.4, 2 uM rotenone, 
1 uM CsA. CsA was a kind gift of Dr. Roland Wenger, Sandoz 
Pharma (Basel, Switzerland). All other chemicals were of the highest 
available grade and were purchased from Sigma (St. Louis, MO). 
3. Results and discussion 
P G O reacts with the guanidino group of arginine under 
mildly alkaline conditions to form a stable derivative [10]. 
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Fig. 1. Inhibition of the PT by PGO. Dependence on concentration and incubation time. Panel A: mitochondria pre-incubated for 15 min with 
PGO, as described in Section 2, were washed and re-suspended at 0.25 mg protein X ml"1 in a buffer containing 250 mM sucrose, 10 mM 
HEPES-Tris pH 7.4, 1 mM Pi-Tris, 10 uM Ca2+, 2 uM rotenone. The concentration of PGO during pre-incubation was 0 (traces a-b), 0.1 
mM (trace c), 0.5 mM (trace d) and 1.0 mM (trace e). In trace b, control mitochondria were re-suspended in the presence of 1 uM CsA. The 
reaction was started by addition of 3 mM succinate-Tris (succ) followed, were indicated, by 0.1 (xM RR and 0.8 uM FCCP (RR+FCCP). Swel-
ling was measured as the decrease in light scattering at 570 nm and the initial absorbance A0 was set as 1. Panel B: mitochondria were pre-in-
cubated for 15 min with the indicated concentrations of PGO and the experiments were performed as in panel A. Values on the ordinate refer 
to the absorbance of the suspension 10 min after the addition of RR+FCCP. Panel C: mitochondria were pre-incubated with 1 mM PGO for 
the time indicated on the abscissa and the experiments were performed as in panel A. Values on the ordinate refer to the absorbance of the 
suspension 10 min after the addition of RR+FCCP. 
To address the potential role of arginine residues in the PT, 
mitochondria were pre-incubated with PGO for 15 min at pH 
8.0, followed by washout of excess reagent. The experiments 
reported in Fig. 1A show that in respiring, control mitochon-
dria accumulation of Ca2+ from the suspension buffer fol-
lowed by addition of ruthenium red (RR) and the uncoupler 
carbonylcyanide-p-trifluoromethoxyphenyl hydrazone (FCCP) 
resulted in swelling (trace a), which was completely inhibited 
by CsA (trace b). This was expected since depolarization of 
the mitochondrial membrane when the matrix Ca2+ concen-
tration is high triggers opening of the PT pore, resulting in 
extensive diffusion of sucrose from the external medium [4]. In 
mitochondria pre-treated with PGO, swelling was inhibited 
(Fig. 1A, traces c-e), the half-maximal effect being observed 
at 0.3 mM PGO (Fig. IB). Addition of PGO directly to the 
cuvette immediately prior to the experiment did not inhibit 
the pore under these conditions (not shown). Pore inhibition 
by PGO was dependent on the pre-incubation time, a ti/2 of 
4 min being obtained at 1 mM PGO (Fig. 1C). These results 
demonstrate that treatment of mitochondria with PGO at 
alkaline pH results in a stable protein modification, causing 
in turn inhibition of the PT pore induced by membrane de-
polarization. 
Since opening of the PT pore is critically dependent on 
Ca2+ uptake, we studied whether PGO pre-incubation affected 
the extent of mitochondrial Ca2+ accumulation. As expected, 
control mitochondria rapidly accumulated Ca2+ following en-
ergization with succinate, as detected from the change in ab-
sorbance of arsenazo III (Fig. 2, traces a-b). After completion 
of Ca2+ uptake, the addition of RR and FCCP induced a 
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rapid Ca2+ release (trace a) which was inhibited by CsA (trace 
b), indicating that the PT pore served as the major pathway 
for Ca2+ release under these conditions. Although mitochon-
dria pre-treated with PGO accumulated Ca2+ at a slower rate 
than untreated mitochondria, the final accumulation was iden-
tical (traces c-e). Addition of RR and FCCP to PGO-treated 
mitochondria after completion of Ca2+ uptake, however, re-
sulted in a much slower rate of Ca2+ release (traces c-e), 
consistent with a concentration-dependent inhibition of the 
PT pore. An identical result was obtained if dinitrophenol 
was used instead of FCCP (not shown), indicating that 
PGO was not acting through an effect on the putative 
FCCP receptor [14]. Furthermore, Au/ measurements in 
PGO-treated mitochondria in the absence of externally added 
Ca2+ indicated a complete collapse of Ai|f by 0.8 uM FCCP 
(not shown). These results demonstrate that inhibition of the 
PT by PGO pre-treatment was not the consequence of an 
impaired capacity of Ca2+ uptake, nor was it due to a de-
creased mitochondrial sensitivity to FCCP. 
Since pre-treatment with PGO induced an inhibition of the 
rate of Ca2+ accumulation, we next assessed the basis for this 
effect. Direct inhibition of the Ca2+ uniporter, which mediates 
Ca2+ uptake in energized mitochondria, appeared extremely 
unlikely because partial inhibition of this channel with ruthe-
nium red dramatically altered Ca2+ distribution (not shown), 
which is not observed here (Fig. 2). We then assessed whether 
the effect of PGO could be linked to an impaired generation 
of the major driving force for Ca2+ uptake (the A\j/) through 
inhibition of the respiratory chain or of substrate transport. 
The experiments of Fig. 3 show the effect of PGO treatment 
on respiration with succinate as a substrate. While the basal 
state 4 oxygen consumption was unaffected, a strong inhibi-
tion of uncoupled respiration was observed, suggesting that 
inhibition of Ca2+ uptake in PGO-treated mitochondria re-
sults from partial inhibition of respiration. Since maximal 
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Fig. 2. Inhibition of Ca2+ release by PGO. Mitochondria pre-treated 
for 15 min with PGO at a concentration of 0 (traces a-b), 0.1 mM 
(trace c), 0.5 mM (trace d) or 1 mM (trace e) were re-suspended in 
the same incubation medium described in Fig. 1 supplemented with 
20 uM arsenazo III. In trace b, control mitochondria were re-sus-
pended in the presence of 1 |xM CsA. The reaction was started by 
addition of 4 mM succinate (succ), followed were indicated by 0.1 
uM RR and 0.8 uM FCCP (RR+FCCP). Absorbance was meas-
ured at the wavelength couple 653-684 nm. 
PGO (mM) 
Fig. 3. Effect of PGO on respiration. Mitochondria pre-incubated 
with the concentrations of PGO indicated on the abscissa were sus-
pended at 0.375 mg protein Xmr1 in a buffer containing 250 mM 
sucrose, 10 mM HEPES-Tris pH 7.4, 5 mM succinate-Tris, 1 mM 
Pi-Tris, 10 uM EGTA-Tris, 2 |iM rotenone. After recording the 
basal respiration rate (closed symbols), uncoupled respiration was 
measured after addition of 200 nM FCCP (open symbols). 
respiration was not inhibited by PGO treatment in hypotoni-
cally ruptured mitochondria (by re-suspension in 1 mM 
HEPES pH 7.4, results not shown), we conclude that inhib-
ition of respiration by PGO is due to inhibition of substrate 
transport rather than of the respiratory chain. 
It must be stressed that, due to the increased probability of 
pore opening caused by depolarization [4,5], partial respira-
tory inhibition by PGO as such should have promoted rather 
than inhibited the PT. To test this prediction, we carried out 
experiments similar to those reported in Fig. 2. After accumu-
lation of Ca2+ by control mitochondria, sufficient antimycin A 
was added to induce a slow release of Ca2+. Addition of CsA 
at this point caused a slow but complete reuptake of the 
released Ca2+, demonstrating that partial inhibition of respi-
ration results in pore opening rather than in its inhibition 
(results not shown). We conclude that partial inhibition of 
respiration by PGO cannot explain its inhibitory effect on 
the pore. Rather, this leads to an underestimation of the in-
hibitory effects of PGO on the PT pore. 
Since the PT pore is stimulated by matrix Pi [1], we also 
investigated whether pore inhibition by PGO could be ex-
plained by inhibition of Pi transport. This was not the case 
since nigericin-induced swelling of deenergized mitochondria 
in isotonic KPi medium was indistinguishable in PGO-treated 
and control mitochondria (data not shown). 
We think that the most likely mechanism underlying the 
observed effects of PGO is arginine modification because the 
reaction was rapid, it occurred at low PGO concentrations 
and it was favored by mildly alkaline pH (Fig. 1) [10]. We 
note, however, that PGO can also react to some extent with 
lysine side chains and N-terminal amino groups. Therefore, 
we cannot exclude that chemical modification also affects oth-
er residues. We note, however, that conserved arginine and 
lysine residues are believed play a key role in voltage sensing 
by the plasma membrane K+, Na2+ and Ca2+ channels [15]. 
Taken together, the present observations further point at 
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the importance of pore modulat ion by the t ransmembrane 
voltage. Although much more work will be needed to clarify 
the exact mechanism by which P G O causes pore inhibition 
and the nature and location of the PGO-reactive sites, our 
study offers a new tool for site-directed modification of pore 
function at one of its key control points. 
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